P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α

Cancer Letters

Volumn 340, Issue 1, 2013, Pages 22-29

  Liu, Kevin H ^a   Huynh, Nhi ^a   Patel, Oneel ^a   Shulkes, Arthur ^a   Baldwin, Graham ^a   He, Hong ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Catenin; CRC; HIF 1 ; PAK1

Indexed keywords

BETA CATENIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; P21 ACTIVATED KINASE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL DEATH; CELL HYPOXIA; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR XENOGRAFT; UPREGULATION;

Β-CATENIN; CRC; HIF-1Α; PAK1;

ANIMALS; BETA CATENIN; CELL HYPOXIA; CELL SURVIVAL; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; P21-ACTIVATED KINASES; RNA, SMALL INTERFERING; TUMOR BURDEN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84883786257     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.06.024     Document Type: Article

References (31)

1. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Research 1989, 49:4682-4689.
2. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103:311-320.
3. Rosin-Arbesfeld R., Townsley F., Bienz M. The APC tumour suppressor has a nuclear export function. Nature 2000, 406:1009-1012.
4. Janssen K.P., Alberici P., Fsihi H., Gaspar C., Breukel C., Franken P., Rosty C., Abal M., El Marjou F., Smits R., Louvard D., Fodde R., Robine S. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 2006, 131:1096-1109.
5. Luo F., Brooks D.G., Ye H., Hamoudi R., Poulogiannis G., Patek C.E., Winton D.J., Arends M.J. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. International Journal of Experimental Pathology 2009, 90:558-574.
6. Carter J.H., Douglass L.E., Deddens J.A., Colligan B.M., Bhatt T.R., Pemberton J.O., Konicek S., Hom J., Marshall M., Graff J.R. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clinical Cancer Research 2004, 10:3448-3456.
7. Huynh N., Liu K.H., Baldwin G.S., He H. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways. Biochimica et Biophysica Acta 1803, 2010:1106-1113.
8. He H., Huynh N., Liu K.H., Malcontenti-Wilson C., Zhu J., Christophi C., Shulkes A., Baldwin G.S. P-21 activated kinase 1 knockdown inhibits beta-catenin signalling and blocks colorectal cancer growth. Cancer Letters 2012, 317:65-71.
9. Zhu G., Wang Y., Huang B., Liang J., Ding Y., Xu A., Wu W. A Rac1/PAK1 cascade controls beta-catenin activation in colon cancer cells. Oncogene 2012, 31:1001-1012.
10. He H., Baldwin G.S. P21-activated kinases and gastrointestinal cancer. Biochimica et Biophysica Acta 1833, 2013:33-39.
11. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends in Molecular Medicine 2002, 8:S62-S67.
12. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute 2001, 93:266-276.
13. Kaidi A., Williams A.C., Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nature Cell Biology 2007, 9:210-217.
14. Kikuchi H., Pino M.S., Zeng M., Shirasawa S., Chung D.C. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer. Cancer Research 2009, 69:8499-8506.
15. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
16. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes and Development 2001, 15:188-200.
17. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2718-2723.
18. Semenza G.L. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochemical Pharmacology 2000, 59:47-53.
19. 2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Annals of the New York Academy of Sciences 2002, 973:443-447.
20. Colnot S., Niwa-Kawakita M., Hamard G., Godard C., Le Plenier S., Houbron C., Romagnolo B., Berrebi D., Giovannini M., Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Laboratory Investigation; A Journal of Technical Methods and Pathology 2004, 84:1619-1630.
21. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., Simons J.W., Semenza G.L. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Research 2000, 60:1541-1545.
22. Hudson C.C., Liu M., Chiang G.G., Otterness D.M., Loomis D.C., Kaper F., Giaccia A.J., Abraham R.T. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Molecular and Cellular Biology 2002, 22:7004-7014.
23. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. The Journal of Biological Chemistry 2002, 277:38205-38211.
24. Hur E., Chang K.Y., Lee E., Lee S.K., Park H. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Molecular Pharmacology 2001, 59:1216-1224.
25. Sang N., Stiehl D.P., Bohensky J., Leshchinsky I., Srinivas V., Caro J. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. The Journal of Biological Chemistry 2003, 278:14013-14019.
26. Otrock Z.K., Hatoum H.A., Awada A.H., Ishak R.S., Shamseddine A.I. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Critical Reviews in Oncology/Hematology 2009, 70:93-102.
27. Kuwai T., Kitadai Y., Tanaka S., Onogawa S., Matsutani N., Kaio E., Ito M., Chayama K. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. International Journal of Cancer. Journal International du Cancer 2003, 105:176-181.
28. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
29. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., Hankinson O., Pugh C.W., Ratcliffe P.J. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:8104-8109.
30. Cao D., Hou M., Guan Y.S., Jiang M., Yang Y., Gou H.F. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 2009, 9:432.
31. Xia Y., Choi H.K., Lee K. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. European Journal of Medicinal Chemistry 2012, 49:24-40.